For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Novavax, Inc. (NASDAQ: NVAX) closed at $12.91 up 3.12% from its previous closing price of $12.52. In other words, the price has increased by $3.12 from its previous closing price. On the day, 8.91 million shares were traded. NVAX stock price reached its highest trading level at $13.36 during the session, while it also had its lowest trading level at $12.344.
Ratios:
For a deeper understanding of Novavax, Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.03 and its Current Ratio is at 1.04.
BofA Securities Upgraded its Underperform to Neutral on May 10, 2024, whereas the target price for the stock was revised from $4 to $12.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 18 ’24 when Dubovsky Filip bought 7,335 shares for $13.00 per share.
YOUNG JAMES F sold 7,500 shares of NVAX for $105,675 on Jun 21 ’24. The Director now owns 61,760 shares after completing the transaction at $14.09 per share. On Jun 18 ’24, another insider, YOUNG JAMES F, who serves as the Director of the company, sold 7,500 shares for $13.72 each. As a result, the insider received 102,881 and left with 69,260 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVAX now has a Market Capitalization of 2066813568 and an Enterprise Value of 1280751872. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.09. Its current Enterprise Value per Revenue stands at 1.297 whereas that against EBITDA is -5.318.
Stock Price History:
Over the past 52 weeks, NVAX has reached a high of $23.86, while it has fallen to a 52-week low of $3.53. The 50-Day Moving Average of the stock is -0.89%, while the 200-Day Moving Average is calculated to be 47.18%.
Shares Statistics:
For the past three months, NVAX has traded an average of 6.98M shares per day and 6278870 over the past ten days. A total of 160.09M shares are outstanding, with a floating share count of 153.03M. Insiders hold about 4.42% of the company’s shares, while institutions hold 52.35% stake in the company. Shares short for NVAX as of 1724976000 were 31608767 with a Short Ratio of 4.53, compared to 1722384000 on 28757720. Therefore, it implies a Short% of Shares Outstanding of 31608767 and a Short% of Float of 24.63.
